Literature DB >> 15172502

Low toxicity of cationic lipid-based emulsion for gene transfer.

Woo-Jeong Choi1, Jin-Ki Kim, Sung-Hee Choi, Jeong-Sook Park, Woong Shick Ahn, Chong-Kook Kim.   

Abstract

Cationic liposome has been studied as one of the most promising non-viral gene delivery systems. However, it has major drawbacks such as the formation of large aggregates at higher concentrations and the instability in the serum due to cationic lipid. As an alternative gene delivery system, cationic emulsion was formulated and transfection efficiency was evaluated in vitro and in vivo, in comparison with cationic liposome. Cationic emulsion was prepared with varying compositions of 3 beta [N-(N',N'-dimethylaminoethane) carbamoyl] cholesterol (DC-Chol), dioleoylphosphatidyl ethanolamine (DOPE), caster oil and Tween 80. Cationic liposome was prepared with DC-Chol and DOPE. The particle size of all the DNA/lipid complexes varied from 150 to 230 nm. The in vitro transfection efficiency of plasmid DNA was assessed by the expression of green fluorescent protein as a reporter. Of various formulations, cationic emulsion E2 (DC-Chol/DOPE/Castor Oil/Tween 80 = 0.3:0.3:0.3:0.15) and cationic liposome L3 (DC-Chol/DOPE = 0.6:0.3) showed improved transfection. DNA/E2 complexes exhibited higher transfection efficiencies (17.39+/-0.58%) in comparison with DNA/L3 complexes (11.47+/-0.59%). DNA/E2 complexes also showed a better physical stability and a stronger serum resistance than DNA/L3 complexes. Moreover, the cytotoxicity of DNA/E2 complexes was comparable to that of DNA/L3 complexes. When DNA/lipid complexes were intravenously administered, DNA/E2 complexes showed a prolonged circulation in blood and mRNA expression in various tissues compared with DNA/L3 complexes. These results suggest that cationic emulsion E2 could be a potential gene delivery system in clinical approaches because of enhanced in vivo gene transfer with low toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172502     DOI: 10.1016/j.biomaterials.2004.01.031

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

Authors:  Luis A Brito; Michelle Chan; Christine A Shaw; Armin Hekele; Thomas Carsillo; Mary Schaefer; Jacob Archer; Anja Seubert; Gillis R Otten; Clayton W Beard; Antu K Dey; Anders Lilja; Nicholas M Valiante; Peter W Mason; Christian W Mandl; Susan W Barnett; Philip R Dormitzer; Jeffrey B Ulmer; Manmohan Singh; Derek T O'Hagan; Andrew J Geall
Journal:  Mol Ther       Date:  2014-07-16       Impact factor: 11.454

2.  Polysorbate cationic synthetic vesicle for gene delivery.

Authors:  Yongzhuo Huang; Yuefeng Rao; Jinliang Chen; Victor C Yang; Wenquan Liang
Journal:  J Biomed Mater Res A       Date:  2011-01-04       Impact factor: 4.396

Review 3.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

4.  Effects of Tissue-Type Plasminogen Site-Specific Transgene in Gelatin-Coated Dacron on the Fibrinolysis Activity of Rabbit Left Atrium.

Authors:  Xiaobin Liu; Kailun Zhang; Xionggang Jiang; Jiahong Xia; Daokang Xiang
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

5.  Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.

Authors:  Jinju Lee; Phei Er Saw; Vipul Gujrati; Yonghyun Lee; Hyungjun Kim; Sukmo Kang; Minsuk Choi; Jae-Il Kim; Sangyong Jon
Journal:  Theranostics       Date:  2016-01-01       Impact factor: 11.556

Review 6.  Lipid-Based Drug Delivery Systems.

Authors:  Hina Shrestha; Rajni Bala; Sandeep Arora
Journal:  J Pharm (Cairo)       Date:  2014-05-19

Review 7.  Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.

Authors:  Alicia Rodríguez-Gascón; Ana del Pozo-Rodríguez; María Ángeles Solinís
Journal:  Int J Nanomedicine       Date:  2014-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.